CA2893158A1 - Method for evaluation of presence of or risk of colon tumors - Google Patents

Method for evaluation of presence of or risk of colon tumors Download PDF

Info

Publication number
CA2893158A1
CA2893158A1 CA2893158A CA2893158A CA2893158A1 CA 2893158 A1 CA2893158 A1 CA 2893158A1 CA 2893158 A CA2893158 A CA 2893158A CA 2893158 A CA2893158 A CA 2893158A CA 2893158 A1 CA2893158 A1 CA 2893158A1
Authority
CA
Canada
Prior art keywords
proteins
subject
adenoma
amount
polyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2893158A
Other languages
English (en)
French (fr)
Inventor
John Blume
Ryan BENZ
Lisa CRONER
Roslyn DILLON
Arlo RANDALL
Jeffrey Jones
Heather SKOR
Tom STOCKFISCH
Bruce Wilcox
Daniel RUDERMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Proteomics Inc
Original Assignee
Applied Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Proteomics Inc filed Critical Applied Proteomics Inc
Publication of CA2893158A1 publication Critical patent/CA2893158A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/57535—
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
CA2893158A 2012-11-30 2013-12-02 Method for evaluation of presence of or risk of colon tumors Abandoned CA2893158A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732024P 2012-11-30 2012-11-30
US61/732,024 2012-11-30
US201361772979P 2013-03-05 2013-03-05
US61/772,979 2013-03-05
PCT/US2013/072691 WO2014085826A2 (en) 2012-11-30 2013-12-02 Method for evaluation of presence of or risk of colon tumors

Publications (1)

Publication Number Publication Date
CA2893158A1 true CA2893158A1 (en) 2014-06-05

Family

ID=50828610

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2893158A Abandoned CA2893158A1 (en) 2012-11-30 2013-12-02 Method for evaluation of presence of or risk of colon tumors

Country Status (11)

Country Link
US (6) US20140234854A1 (show.php)
EP (1) EP2926138A4 (show.php)
JP (1) JP2016507723A (show.php)
KR (1) KR20150090240A (show.php)
CN (2) CN110596385A (show.php)
AU (1) AU2013351947A1 (show.php)
BR (1) BR112015012616A2 (show.php)
CA (1) CA2893158A1 (show.php)
MX (1) MX2015006757A (show.php)
SG (1) SG11201504241QA (show.php)
WO (1) WO2014085826A2 (show.php)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
EP3367099B1 (en) 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CA2943827A1 (en) * 2014-03-28 2015-10-01 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
KR20190080973A (ko) * 2014-07-11 2019-07-08 익스프레션 패톨로지, 인크. GTPase KRas 단백질(KRas)에 대한 SRM/MRM 검정
EP3699930B1 (en) 2014-08-14 2024-02-07 MeMed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
CA2963785A1 (en) * 2014-09-05 2016-03-10 Nantomics, Llc Systems and methods for determination of provenance
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
AU2015360420B2 (en) * 2014-12-11 2021-12-09 Wisconsin Alumni Research Foundation Methods for detection and treatment of colorectal cancer
CN105807062A (zh) * 2014-12-28 2016-07-27 复旦大学 人结肠癌蛋白Spondin-2在制备结肠癌诊断制剂中的应用
CN105385752A (zh) * 2015-03-23 2016-03-09 复旦大学 一种人结肠癌蛋白质标志物Spondin-2的检测方法及其检测试剂盒
US9689874B2 (en) 2015-04-10 2017-06-27 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CA2989199A1 (en) * 2015-07-01 2017-01-05 Duke University Methods to diagnose and treat acute respiratory infections
US11047860B2 (en) * 2015-11-05 2021-06-29 Vanderbilt University Protein quantitation in multicellular tissue specimens
WO2017149548A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
EP3443497A1 (en) * 2016-04-11 2019-02-20 DiscernDx, Inc. Mass spectrometric data analysis workflow
JP6754116B2 (ja) * 2016-04-26 2020-09-09 学校法人近畿大学 大腸癌マーカー
CN107345236A (zh) * 2016-05-04 2017-11-14 北京美泽福临科技发展有限公司 一种amy2b信使rna的特异性扩增引物和肝癌辅助诊断试剂盒
WO2017214625A1 (en) * 2016-06-10 2017-12-14 Wisconsin Alumni Research Foundation Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
CN106202984B (zh) * 2016-08-26 2018-09-04 赵毅 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
US11353456B2 (en) * 2016-09-29 2022-06-07 Memed Diagnostics Ltd. Methods of risk assessment and disease classification for appendicitis
US20180100858A1 (en) * 2016-10-07 2018-04-12 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US11423331B2 (en) 2017-01-19 2022-08-23 Shimadzu Corporation Analytical data analysis method and analytical data analyzer
US11204355B2 (en) 2017-02-20 2021-12-21 Vanderbilt University Immune checkpoint molecular fitness profiling by mass spectrometry
CN106919801B (zh) * 2017-03-08 2023-07-18 杭州大伽信息科技有限公司 一种免疫组织化学染色辅助分析系统及使用方法
CN106908608B (zh) * 2017-04-17 2018-10-02 首都医科大学附属北京胸科医院 辅助诊断重症继发性肺结核的蛋白标志物
US20180330059A1 (en) * 2017-05-09 2018-11-15 James Stewart Bates Patient treatment systems and methods
US10455457B2 (en) 2017-05-24 2019-10-22 Qualcomm Incorporated NR-SS unified operation mode in coordinated and uncoordinated bands
US11164679B2 (en) 2017-06-20 2021-11-02 Advinow, Inc. Systems and methods for intelligent patient interface exam station
TW201905461A (zh) * 2017-06-30 2019-02-01 國立研究開發法人醫藥基盤．健康．營養研究所 用以檢測大腸癌之生物標記
CA3069828A1 (en) * 2017-07-14 2019-01-17 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
CN109406785A (zh) * 2017-08-18 2019-03-01 山东泽济生物科技有限公司 肿瘤血液标志物及其应用
WO2019113239A1 (en) * 2017-12-05 2019-06-13 Discerndx, Inc. Robust panels of colorectal cancer biomarkers
AU2018395255B2 (en) * 2017-12-29 2025-02-20 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
ES2917629T3 (es) 2018-01-22 2022-07-11 Liquid Biopsy Res Llc Métodos para la detección del cáncer de colon y monitorización del tratamiento
US11348688B2 (en) 2018-03-06 2022-05-31 Advinow, Inc. Systems and methods for audio medical instrument patient measurements
JP7455757B2 (ja) * 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装
US20200011871A1 (en) * 2018-07-05 2020-01-09 Edp Biotech Corporation Kits and methods for detecting markers
KR20210043589A (ko) 2018-08-08 2021-04-21 리제너론 파마슈티칼스 인코포레이티드 단백질 바이오마커를 정량화하기 위한 lc-ms/ms의 용도
EP3623813A1 (en) * 2018-09-17 2020-03-18 Institut d'Investigació Sanitària Pere Virgili Methods for the prognosis of hiv-infected subjects
JP7539399B2 (ja) * 2019-03-06 2024-08-23 ディアデム エス．アール．エル． アルツハイマー病の診断と予後判定におけるマーカーとしてのｐ５３ペプチド
US12499537B2 (en) * 2019-11-13 2025-12-16 University Of South Florida Systems and methods of deep learning for colorectal polyp screening
CN110951707B (zh) * 2019-12-31 2022-11-11 南京医科大学 丙酮酸激酶m2突变体及其在心血管疾病中的应用
CN115616230A (zh) * 2020-03-18 2023-01-17 龙海市第一医院 用于肝癌早期诊断的检测岩藻糖基化载脂蛋白h的elisa试剂盒
WO2022006628A1 (en) * 2020-07-08 2022-01-13 Southern Adelaide Local Health Network Inc. Computer-implemented method and system for identifying measurable features for use in a predictive model
CN112194719A (zh) * 2020-09-01 2021-01-08 中日友好医院(中日友好临床医学研究所) Crt抗原和mage-a1抗原的制备及其应用
CN112034182A (zh) * 2020-09-01 2020-12-04 复旦大学附属中山医院 一种结肠癌转移预测方法和系统
CN112266961B (zh) * 2020-10-29 2023-05-12 中山大学附属第六医院 Tsg-6基因在预测结直肠癌转移及预后方面的应用
CN112710856B (zh) * 2020-12-16 2022-12-02 江西省肿瘤医院(江西省癌症中心) 检测血清igf1蛋白的制剂在制备结直肠癌疗效监测试剂中的应用
CN113447658B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗过氧化物还原酶-1-IgG抗体的试剂盒
CN113956327B (zh) * 2021-10-11 2024-01-30 中山大学肿瘤防治中心 靶向人apc蛋白的多肽及其在制备药物中的应用
EP4497005A1 (en) * 2022-03-23 2025-01-29 Serum Detect, Inc. Biomarker signatures indicative of early stages of cancer
CN114445406B (zh) * 2022-04-07 2022-08-09 武汉大学 肠镜图像分析方法、装置和医学图像处理设备
TWI796228B (zh) 2022-05-25 2023-03-11 臺中榮民總醫院 急性腎損傷預測系統及其方法
CN114668836B (zh) * 2022-05-27 2022-08-19 暨南大学 Pdia6在制备治疗脊髓损伤和修复的药物中的应用
CN114958794B (zh) * 2022-06-14 2023-06-02 南京工业大学 一种苯乙醇胺-N-甲基转移酶hPNMT54及其克隆表达与应用
CN116593431B (zh) * 2023-04-09 2025-11-07 湖南科技大学三亚研究院 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法
WO2024232926A1 (en) * 2023-05-08 2024-11-14 Venn Biosciences Corporation Diagnosis of colorectal cancer using targeted quantification of peptides
WO2025058445A1 (ko) * 2023-09-15 2025-03-20 연세대학교 산학협력단 대장암에 대한 정보 제공 방법
CN118067993B (zh) * 2024-04-17 2024-07-05 弗雷米德生物医药技术（天津）有限公司 一种用于肠息肉检测的联检试剂盒及其制备方法、检测方法和应用
CN118496322A (zh) * 2024-05-09 2024-08-16 昆明医科大学 一种靶向降解β-catenin的多肽型抑制剂及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
CA2228970A1 (en) * 1995-08-18 1997-02-27 Donald W. Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
NO954667D0 (no) * 1995-11-17 1995-11-17 Dagfinn Oegreid Fremgangsmåte til deteksjon av Ki-ras mutasjoner
EP1179092A2 (en) * 1999-01-10 2002-02-13 Exact Sciences Corporation Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
US20010041365A1 (en) * 2000-01-10 2001-11-15 Michael Laposata Methods for monitoring alcohol consumption
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
EP2026071B1 (en) * 2004-02-19 2013-07-31 Yale University Identification of cancer protein biomarkers using proteomic techniques
PT1761779E (pt) * 2004-08-13 2008-02-01 Indivumed Gmbh Utilização de transtirretina como um biomarcador de adenoma colorrectal; método de detecção e sistema de teste
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
WO2006094149A2 (en) * 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
CN101283280A (zh) * 2005-08-18 2008-10-08 Zadec私人有限公司 用于诊断结直肠癌的蛋白质标记和所述标记作为所述癌症类型治疗的药物靶点的用途
WO2007141595A2 (en) * 2005-11-10 2007-12-13 Aurelium Biopharma Inc. Method of diagnosing breast cancer using protein markers
CN101802616B (zh) * 2007-07-19 2014-10-15 生物梅里埃公司 体外诊断结肠直肠癌的肝脂肪酸结合蛋白、cea和ca19-9测定方法
EP2195658A2 (en) * 2007-09-28 2010-06-16 Royal College of Surgeons in Ireland A method of assessing colorectal cancer status in an individual
ATE524740T1 (de) * 2007-12-10 2011-09-15 Hoffmann La Roche Seprase als krebsmarker
JP5591711B2 (ja) * 2007-12-10 2014-09-17 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌のためのマーカーパネル
JP2011511635A (ja) * 2008-02-11 2011-04-14 ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド 癌標識としての結腸癌関連転写因子１（ｃｃａｔ−１）
WO2009107170A1 (ja) * 2008-02-29 2009-09-03 学校法人日本大学 抗ｃｒｐ抗体及びその利用
WO2009115920A1 (en) * 2008-03-18 2009-09-24 Epigenomics Ag A method for optimizing and validating an assay for determining the presence or absence of a medical condition
US20110065605A1 (en) * 2008-05-14 2011-03-17 Eth Zurich Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
ES2506116T3 (es) * 2008-05-23 2014-10-13 Biocartis Nv Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
EP2488659B1 (en) * 2009-10-15 2019-12-11 Crescendo Bioscience, Inc. Biomarkers and methods for measuring and monitoring inflammatory disease activity
US10119959B2 (en) * 2010-06-25 2018-11-06 The Board Of Trustees Of The Leland Stanford Junior University Method of assaying an individual for immune impairment
ES2545515T3 (es) * 2011-01-28 2015-09-11 F. Hoffmann-La Roche Ag Biomarcadores combinatorios para aplicaciones clínicas en la gestión del paciente con cáncer de pulmón
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 循環バイオマーカー
EP2744919A4 (en) * 2011-08-19 2015-04-08 Myriad Genetics Inc GENE SIGNATURES FOR PROGNOSIS OF LUNG CANCER AND SELECTION OF THERAPY

Also Published As

Publication number Publication date
CN104969071A (zh) 2015-10-07
JP2016507723A (ja) 2016-03-10
US20150111230A1 (en) 2015-04-23
US20140234854A1 (en) 2014-08-21
US20150111221A1 (en) 2015-04-23
EP2926138A4 (en) 2016-09-14
WO2014085826A3 (en) 2014-10-23
SG11201504241QA (en) 2015-06-29
US20170285033A1 (en) 2017-10-05
EP2926138A2 (en) 2015-10-07
MX2015006757A (es) 2015-11-30
CN110596385A (zh) 2019-12-20
KR20150090240A (ko) 2015-08-05
US20150111220A1 (en) 2015-04-23
US20150111223A1 (en) 2015-04-23
CN104969071B (zh) 2019-09-03
BR112015012616A2 (pt) 2017-09-12
AU2013351947A1 (en) 2015-06-18
WO2014085826A2 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
US20170285033A1 (en) Method for evaluation of presence of or risk of colon tumors
US9689874B2 (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
JP7584486B2 (ja) 乾癬性関節炎の疾患活動性を評価するためのバイオマーカーおよび方法
US20170176441A1 (en) Protein biomarker profiles for detecting colorectal tumors
US20140073522A1 (en) Pancreatic Cancer Biomarkers and Uses Thereof
US20180100858A1 (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
JP2014512520A (ja) 照合性細胞ベースのアッセイ及びその使用
WO2008064336A9 (en) Autoimmune disease biomarkers
HK1248316A1 (en) Methods of assessing colorectal health of an individual
US20240393337A1 (en) Lung Cancer Prediction and Uses Thereof
CA3216160A1 (en) Biomarkers for colorectal cancer
KR20230085151A (ko) 심혈관 사건 위험 예측

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20191203